Status:
UNKNOWN
Sirtuin1 in COVID19 Patients
Lead Sponsor:
Assiut University
Conditions:
Covid19
Eligibility:
All Genders
18-65 years
Brief Summary
1. Evaluate serum level of NAD,Sirtuin1,ADAM17 andPARP1 in covid19 patients 2. Investigate the correlation between measured biomarkers and each other 3. Investigate the correlation between measured bi...
Detailed Description
December 2019, a number of cases of pneumonia with fever, cough, and dyspnea as clinical manifestations have been found in Wuhan, Hubei Province, China (Huang C et al., 2020) The analysis of the whole...
Eligibility Criteria
Inclusion
- Patient adult age 18years and over(higher incidence) presented to Assiut University Hospital from 1december2020 to 30march.2021(winter2021-second wave)
- Suspected of covid19 beacuse of the presence of symptoms suggestive of pneumonia (fever\>38) and at least one of the following symptoms ;cough, dyspnea, tachpnea or hypoxia
- having undergone RT-PCR (confirmed positive PCR)
- Chest CT within 5 days of initial PCR
Exclusion
- Cases less than 18 years old
- Cases express a dissent from the use of their data in the syudy
- Cancer patients (affect result of study as they have disrubted level of these biomarker)
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2023
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT04907916
Start Date
June 1 2021
End Date
January 1 2023
Last Update
June 1 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.